Heart Under Pressure: Divergent Cardiac Molecules Responses to Azathioprine and Anti-TNF Therapy in Ulcerative Colitis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010160 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mirjana Cvetković und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital Medical Center Bežanijska kosa, 11080 Belgrade, Serbia. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Azathioprine, Immunosuppressive Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The treatment of moderate-to-severe ulcerative colitis often requires escalation from 5-ASA therapy to immunosuppressants or biologic agents. However, the effects of azathioprine and anti-TNF therapies on cardiac status and associated biomolecules remain insufficiently studied. In this prospective observational study, we included 84 patients with moderate-to-severe ulcerative colitis, divided into three treatment groups based on the therapy received (azathioprine, infliximab, or adalimumab), along with 25 healthy controls. Levels of proBNP, NT-proBNP, creatine kinase (CK), CK-MB, and high-sensitivity troponin I (hsTnI) were measured at baseline, 6 h after treatment initiation, and after 3 months of therapy. Troponin levels did not significantly change across the three time points in any treatment group. In contrast, levels of proBNP, NT-proBNP, CK, and CK-MB significantly decreased after 3 months in patients treated with biologics, whereas a significant increase was observed in the azathioprine group. Further prospective trials are needed to adequately assess the cardiac safety of these therapies, particularly in patients with preexisting cardiac impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Hospital Medical Center Bežanijska kosa, 11080 Belgrade, Serbia.
- Department of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
- Clinic for Cardiology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.
- Clinic for Gastroenterology and Hepatology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.
- Department of Surgery, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
- Clinic for General Surgery, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.
ORCID-Profile: Stefan Simović, Dušan Radojević, Mladen Maksić, Bojan Stojanović, Željko Todorović, Nebojša Zdravković
Zitieren
APA
Cvetković, M., Simović, S., Radojević, D., Maksić, M., Zdravković, N., Milošević, B., Stojanović, B., Stolić, R., Todorović, Ž., Gogić, A., Zdravković, N., & Zdravković, M. (2025). Heart Under Pressure: Divergent Cardiac Molecules Responses to Azathioprine and Anti-TNF Therapy in Ulcerative Colitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010160
Vancouver
Cvetković M, Simović S, Radojević D, Maksić M, Zdravković N, Milošević B, et al. Heart Under Pressure: Divergent Cardiac Molecules Responses to Azathioprine and Anti-TNF Therapy in Ulcerative Colitis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010160
BibTeX
@article{Cvetkovi2025,
author = {Cvetković, Mirjana and Simović, Stefan and Radojević, Dušan and Maksić, Mladen and Zdravković, Nataša and Milošević, Bojan and Stojanović, Bojan and Stolić, Radojica and Todorović, Željko and Gogić, Anđela and Zdravković, Nebojša and Zdravković, Mateja},
title = {Heart Under Pressure: Divergent Cardiac Molecules Responses to Azathioprine and Anti-TNF Therapy in Ulcerative Colitis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010160}
}
EUVIMED